Skip to content
You are now leaving https://www.ionispharma.com to visit

Advances in Ionis’ Novel Antisense Technology to be Presented at 2018 Society for Neuroscience Meeting

12 presentations highlighting latest data from Ionis’ Neurodegenerative Program including first-in-class therapies for untreatable diseases such as Alzheimer’s, ALS, Alexander, and spinocerebellar ataxia type 3 CARLSBAD, Calif. , Oct. 31, 2018 /PRNewswire/ —  Ionis Pharmaceuticals, Inc.